Page 3 of 4
ChemComm
DOI: 10.1039/C3CC45452E
Figure 4. Xꢀray crystal structure14 of 10b.
AstraZeneca (ER) and EPSRC (RAS, EP/E055346) are
30 acknowledged for funding.
Notes and references
a School of Chemistry, University of Nottingham, Nottingham, NG7 2RD,
UK. E-mail: Robert.stockman@nottingham.ac.uk
b AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, UK:
35 † Electronic Supplementary Information (ESI) available: [Full
experimental details]. See DOI: 10.1039/b000000x/
1. T. C. Nugent (Ed), Chiral Amine Synthesis: Developments and
Applications, WileyꢀVCH: Chichester, UK, 2010.
Figure 3. Xꢀray crystal structure14 of 8b. Structure shown is one of
three independent molecules of compound 8b in the asymmetric unit.
2. For a recent comprehensive review on sulfinimines in synthesis, see:
M. T. Robak, M. A. Herbage and J. A. Ellman, Chem. Rev., 2010,
110, 3600.
Finally we investigated two electronꢀrich aryl bromides as
radical cyclisation precursors (9a and 9b, Scheme 4). In each
case, we found that the reaction was able to proceed, albeit
with modest yield. No other sideꢀproducts or starting material
was isolated from these reactions. Both products were formed
as single diastereoisomers. In the case of thiophene adduct
10 10b, the absolute configuration was confirmed by Xꢀray
crystallography (Figure 4), and we assumed the absolute
stereochemistry of 10a would be that shown by analogy with
10b.
5
3. B. Wang and Y. Wang, Org. Lett., 2009, 11, 3410; B. Wang and R.ꢀ
H. Liu, Eur. J. Org. Chem., 2009, 2845; R. Wang, K. Fang, B.ꢀF.
Sun, M.ꢀH. Xu, and G.ꢀQ. Lin, Synlett, 2009, 2301; R.ꢀC. Liu, K.
Fang, B. Wang, B. F. Sun, M.ꢀH. Xu and G.ꢀQ. Lin, J. Org. Chem.,
2008, 73, 3307; R.ꢀC. Liu, J.ꢀH. Wei, B.ꢀG. Wei and G.ꢀQ. Lin,
Tetrahedron: Asymm., 2008, 19, 2731; Y.ꢀW. Zhong, Y.ꢀZ. Dong, K.
Fang, K. Izumi, M.ꢀH. Xu and G.ꢀQ. Lin, J. Am. Chem. Soc., 2005,
127, 11956.
4. T. Akindele, K. Yamada, T. Seijima, M. Maekawa, Y. Yamamoto,
M. Nakano and K. Tomoika, Chem. Pharm. Bull., 2010, 58, 265; T.
Akindele, Y. Yamamoto, M. Maekawa, H. Umeki, K. Yamada and
K. Tomoika, Org. Lett., 2006, 8, 5729.
5. J. A. FernándezꢀSalas, M. C. Maestro, M. M. RodríguezꢀFernández,
J. L. GarcíaꢀRuano and I. Alonso, Org. Lett., 2013, 15, 1658.
6. For our most recent work in the area of sulfinimine reactivity see: G.
Procopiou, W. Lewis, G. Harbottle and R. A. Stockman, Org. Lett.,
2013, 15, 2030.
7. E. Lacôte and M. Malacria, C. R. Acad. Sci. Paris, 1998, 191.
8. D. L. J. Clive, M. P. Pham and R. Subedi, J. Am. Chem. Soc., 2007,
129, 2713.
O
O
Bu3SnH, AIBN,
O
S
O
O
Br
9a
N
Mes
PhH, reflux
O
HN
S
22%, >98% de
10a
Mes
S
O
Mes
S
N
Bu3SnH, AIBN,
Br
O
S
Mes
PhH, reflux
9. T. MoragasꢀSola, I. Churcher and R. A. Stockman, Org. Biomol
Chem., 2011, 9, 5034.
10. For an excellent workꢀup procedure for tributyl tin hydride reactions,
see: D. C. Harrowven, D. P. Curran, S. L. Kostiuk, I. L. WallisꢀGuy,
S, Whiting, K, J. Stenning, B, Tang, E. Packard and L. Nansona,
Chem. Commun., 2010, 46, 6335.
NH
S
25%, >98% de
9b
10b
Scheme 4. Cyclisation of electronꢀrich aryl bromides
15
11. F. A. Davis, T. Ramachandar and Y. Wu, J. Org. Chem., 2003, 68,
6894.
12. C. Roe, T. MoragasꢀSola, L. SasrakuꢀNeequye, H. Hobbs, I.
Churcher, D. MacPherson and R. A. Stockman, Chem. Commun.,
2011, 4791.
In conclusion, we have found that Sꢀmesitylsulfinimines are
able radical acceptors, and undergo radical cyclisations with
exquisite control of diastereoselectivity. The product chiral
sulfinamines are easily deprotected to give chiral amines
13. C. Roe, H. Hobbs and R. A. Stockman, Chem. Eur. J., 2011, 17,
2704; L. SasrakuꢀNeequaye, D. MacPherson and R. A. Stockman,
Tetrahedron Lett. 2008, 49, 1129.
14. Ellipsoids shown at 50% probability. Crystalꢀdata notes can be found
in the electronic supplementary information.
15. A. Solovyev, SꢀH. Ueng, J. Monot, L. Fensterbank, M. Malacria, E.
lacôte, D.P. Curran, Org. Lett., 2010, 12, 2998; SꢀH. Ueng, L.
Fensterbank, M. Malacria, E. lacôte, D.P. Curran, Org. Lett., 2010,
12, 3002.
20 which have fused aryl/aliphatic and spiro aliphatic ring
systems, making them interesting as chiral building blocks for
screening collection enhancement.16 Further studies are
underway in our laboratories to fully explore the scope and
limitations of this unusually diastereoselective radical
25 cyclisation methodology, which will be reported in due
course.
16. For interesting discussions on “LeadꢀOrientedꢀSynthesis” and threeꢀ
dimensionality in screening compounds and drug discovery see: F.
Lovering, Med. Chem. Commun., 2013, 4, 515; P. MacLellan, A.
Nelson, Chem. Commun., 2013, 49, 24, 238; A. Nadin, C.
Hattotuwagama and I. Churcher, Angew. Chem. Int Ed., 2012, 51,
1114; W. P. Walters, J. Green, J. R. Weiss and M. A. Murcko, J.
Med. Chem., 2011, 54, 6405; F. Lovering, J. Bikker and C. Humbler,
J. Med. Chem., 2009, 52, 6752.
This journal is © The Royal Society of Chemistry [year]
Journal Name, [year], [vol], 00–00 | 3